Meningococcal Vaccine Market in Asia Pacific would register a CAGR of 9.9% during 2020-2026

Published Date: 5-Feb-2021

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Asia Pacific Meningococcal Vaccine Market, published by KBV research, the Asia Pacific Meningococcal Vaccine Market would witness market growth of 9.9% CAGR during the forecast period (2020-2026).

The China market dominated the Asia Pacific Infants (0 to 2 years) Market by Country in 2019, and would continue to be a dominant market till 2026. The India market is anticipated to witness a CAGR of 12.8% during (2020 - 2026). Additionally, The Japan market is exhibiting a CAGR of 12.9% during (2020 - 2026).

The Bexsero market dominated the South Korea Meningococcal Vaccine Market by Brand in 2019, growing at a CAGR of 10.7 % during the forecast period. The Trumenba market is estimated to grow at a CAGR of 11% during (2020 - 2026).

The Quadrivalent market dominated the Malaysia Meningococcal Vaccine Market by Type in 2019, thereby, achieving a market value of $23.1 Million by 2026. The Bivalent market would showcase a CAGR of 11.7% during (2020 - 2026).

Full Report: https://www.kbvresearch.com/asia-pacific-meningococcal-vaccine-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of GlaxoSmithKline PLC (GSK), Pfizer, Inc., Sanofi S.A., Walvax Biotechnology Co., Ltd., Bio-Manguinhos (Oswaldo Cruz Foundation), Bio-Med Pvt. Ltd., Chongqing Zhifei Biological Products Co., Ltd., Hualan Biological Engineering, Inc., Incepta Pharmaceuticals Ltd. and Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)

Asia Pacific Meningococcal Vaccine Market Segmentation

By Brand

  • Bexsero
  • Trumenba
  • Nimenrix
  • Menactra
  • Menveo
  • Other Brands

By Type

  • Bivalent
  • Quadrivalent
  • Other Types

By Age Group

  • Infants (0 to 2 years)
  • Children (2 years & above)

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Sanofi S.A.
  • Walvax Biotechnology Co., Ltd.
  • Bio-Manguinhos (Oswaldo Cruz Foundation)
  • Bio-Med Pvt. Ltd.
  • Chongqing Zhifei Biological Products Co., Ltd.
  • Hualan Biological Engineering, Inc.
  • Incepta Pharmaceuticals Ltd.
  • Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Meningococcal Vaccine Market Related Reports:

Global Market

North America Market

Europe Market

LAMEA Market

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.